Abstract
Vitamin D deficiency is associated with the development of inflammatory bowel disease (IBD). In experimental IBD the targets of vitamin D that result in protection from IBD include gut epithelial cells, innate immune cells, T cells, and the microbiota. Ultraviolet radiation (UVR) induces production of vitamin D in the skin and suppresses T cell responses in the host. There is limited data demonstrating an effect of UVR on experimental IBD but the mechanisms of UVR suppression in IBD have not been defined. There are several shared effects of vitamin D and UVR on T cells including inhibition of proliferation and suppression of IFN-γ and IL-17 producing T cells. Conversely UVR decreases and vitamin D increases IL-4 production from T cells. Together the data suggest that UVR suppression of T cells and potentially IBD are both vitamin D dependent and independent.
Similar content being viewed by others
References
N. A. Molodecky, I. S. Soon, D. M. Rabi, W. A. Ghali, M. Ferris, G. Chernoff, E. I. Benchimol, R. Panaccione, S. Ghosh, H. W. Barkema and G. G. Kaplan, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 2012, 142, 46–54, e42; quiz e30
M. D. Kappelman, S. L. Rifas-Shiman, C. Q. Porter, D. A. Ollendorf, R. S. Sandler, J. A. Galanko and J. A. Finkelstein, Direct health care costs of Crohn’s disease and ulcerative colitis in US children and adults, Gastroenterology, 2008, 135, 1907–1913
R. J. Xavier and D. K. Podolsky, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 2007, 448, 427–434
I. Cleynen, G. Boucher, L. Jostins, L. P. Schumm, S. Zeissig, T. Ahmad, V. Andersen, J. M. Andrews, V. Annese, S. Brand, S. R. Brant, J. H. Cho, M. J. Daly, M. Dubinsky, R. H. Duerr, L. R. Ferguson, A. Franke, R. B. Gearry, P. Goyette, H. Hakonarson, J. Halfvarson, J. R. Hov, H. Huang, N. A. Kennedy, L. Kupcinskas, I. C. Lawrance, J. C. Lee, J. Satsangi, S. Schreiber, E. Theatre, A. E. van der Meulen-de Jong, R. K. Weersma, D. C. Wilson, C. International Inflammatory Bowel Disease Genetics, M. Parkes, S. Vermeire, J. D. Rioux, J. Mansfield, M. S. Silverberg, G. Radford-Smith, D. P. McGovern, J. C. Barrett and C. W. Lees, Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study, Lancet, 2016, 387, 156–167
D. Q. Shih and S. R. Targan, Insights into IBD Pathogenesis, Curr. Gastroenterol. Rep., 2009, 11, 473–480
H. Machida, K. Tsukamoto, C. Y. Wen, Y. Narumi, S. Shikuwa, H. Isomoto, F. Takeshima, Y. Mizuta, N. Niikawa, I. Murata and S. Kohno, Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese, World J. Gastroenterol., 2005, 11, 4188–4193
K. Repnik and U. Potocnik, CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms, DNA Cell Biol., 2010, 29, 603–610
D. J. Philpott, M. T. Sorbara, S. J. Robertson, K. Croitoru and S. E. Girardin, NOD proteins: regulators of inflammation in health and disease, Nat. Rev. Immunol., 2014, 14, 9–23
J. P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J. P. Cezard, J. Belaiche, S. Almer, C. Tysk, C. A. O’Morain, M. Gassull, V. Binder, Y. Finkel, A. Cortot, R. Modigliani, P. Laurent-Puig, C. Gower-Rousseau, J. Macry, J. F. Colombel, M. Sahbatou and G. Thomas, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease, Nature, 2001, 411, 599–603
Y. Ogura, D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, J. P. Achkar, S. R. Brant, T. M. Bayless, B. S. Kirschner, S. B. Hanauer, G. Nunez and J. H. Cho, A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease, Nature, 2001, 411, 603–606
M. T. Cantorna, Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease, Prog. Biophys. Mol. Biol., 2006, 92, 60–64
N. A. Braus and D. E. Elliott, Advances in the pathogenesis and treatment of IBD, Clin. Immunol., 2009, 132, 1–9
D. N. Frank, A. L. St Amand, R. A. Feldman, E. C. Boedeker, N. Harpaz and N. R. Pace, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 13780–13785
X. Q. Tian and M. F. Holick, Catalyzed thermal isomerization between previtamin D3 and vitamin D3 via beta-cyclodextrin complexation, J. Biol. Chem., 1995, 270, 8706–8711
S. Shivananda, J. Lennard-Jones, R. Logan, N. Fear, A. Price, L. Carpenter and M. van Blankenstein, Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD), Gut, 1996, 39, 690–697
E. L. Armitage, M. C. Aldhous, N. Anderson, H. E. Drummond, R. A. Riemersma, S. Ghosh and J. Satsangi, Incidence of juvenile-onset Crohn’s disease in Scotland: association with northern latitude and affluence, Gastroenterology, 2004, 127, 1051–1057
V. Nerich, E. Monnet, A. Etienne, S. Louafi, C. Ramee, S. Rican, A. Weill, N. Vallier, V. Vanbockstael, G. R. Auleley, H. Allemand and F. Carbonnel, Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data, Inflamm. Bowel Dis., 2006, 12, 218–226
V. Nerich, P. Jantchou, M. C. Boutron-Ruault, E. Monnet, A. Weill, V. Vanbockstael, G. R. Auleley, C. Balaire, P. Dubost, S. Rican, H. Allemand and F. Carbonnel, Low exposure to sunlight is a risk factor for Crohn’s disease, Aliment. Pharmacol. Ther., 2011, 33, 940–945
B. N. Limketkai, T. M. Bayless, S. R. Brant and S. M. Hutfless, Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation, Aliment. Pharmacol. Ther., 2014, 40, 508–517
S. M. Govani, P. D. Higgins, R. W. Stidham, S. J. Montain and A. K. Waljee, Increased ultraviolet light exposure is associated with reduced risk of inpatient surgery among patients with Crohn’s disease, J. Crohns Colitis, 2015, 9, 77–81
H. Khalili, E. S. Huang, A. N. Ananthakrishnan, L. Higuchi, J. M. Richter, C. S. Fuchs and A. T. Chan, Geographical variation and incidence of inflammatory bowel disease among US women, Gut, 2012, 61, 1686–1692
S. M. Govani, A. K. Waljee, R. W. Stidham and P. D. Higgins, Increasing ultraviolet light exposure is associated with reduced mortality from Clostridium difficile infection, United Eur. Gastroenterol. J., 2015, 3, 208–214
M. T. Cantorna, S. Yu and D. Bruce, The paradoxical effects of vitamin D on type 1 mediated immunity, Mol. Aspects Med., 2008, 29, 369–375
P. Datta, P. A. Philipsen, P. Olsen, B. Petersen, P. Johansen, N. Morling and H. C. Wulf, Major inter-personal variation in the increase and maximal level of 25-hydroxy vitamin D induced by UVB, Photochem. Photobiol. Sci., 2016, 15, 536–545
C. Lu, J. Yang, W. Yu, D. Li, Z. Xiang, Y. Lin and C. Yu, Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis, PLoS One, 2015, 10, e0132036
M. T. Cantorna, IBD: Vitamin D and IBD: moving towards clinical trials, Nat. Rev. Gastroenterol. Hepatol., 2016, 13, 322–323
A. N. Ananthakrishnan, H. Khalili, L. M. Higuchi, Y. Bao, J. R. Korzenik, E. L. Giovannucci, J. M. Richter, C. S. Fuchs and A. T. Chan, Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease, Gastroenterology, 2012, 142, 482–489
A. N. Ananthakrishnan, A. Cagan, V. S. Gainer, T. Cai, S. C. Cheng, G. Savova, P. Chen, P. Szolovits, Z. Xia, P. L. De Jager, S. Y. Shaw, S. Churchill, E. W. Karlson, I. Kohane, R. M. Plenge, S. N. Murphy and K. P. Liao, Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn’s disease, Inflamm. Bowel Dis., 2013, 19, 1921–1927
T. A. Kabbani, I. E. Koutroubakis, R. E. Schoen, C. Ramos-Rivers, N. Shah, J. Swoger, M. Regueiro, A. Barrie, M. Schwartz, J. G. Hashash, L. Baidoo, M. A. Dunn and D. G. Binion, Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study, Am. J. Gastroenterol., 2016, 13, 322–323
S. P. Jorgensen, C. L. Hvas, J. Agnholt, L. A. Christensen, L. Heickendorff and J. F. Dahlerup, Active Crohn’s disease is associated with low vitamin D levels, J. Crohns Colitis, 2013, 7, e407–e413
M. Waterman, W. Xu, J. M. Stempak, R. Milgrom, C. N. Bernstein, A. M. Griffiths, G. R. Greenberg, A. H. Steinhart and M. S. Silverberg, Distinct and overlapping genetic loci in Crohn’s disease and ulcerative colitis: correlations with pathogenesis, Inflamm. Bowel Dis., 2011, 17, 1936–1942
L. Yang, V. Weaver, J. P. Smith, S. Bingaman, T. J. Hartman and M. T. Cantorna, Therapeutic effect of vitamin d supplementation in a pilot study of Crohn’s patients, Clin. Transl. Gastroenterol., 2013, 4, e33
P. Miheller, G. Muzes, I. Hritz, G. Lakatos, I. Pregun, P. L. Lakatos, L. Herszenyi and Z. Tulassay, Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients, Inflamm. Bowel Dis., 2009, 15, 1656–1662
S. P. Jorgensen, J. Agnholt, H. Glerup, S. Lyhne, G. E. Villadsen, C. L. Hvas, L. E. Bartels, J. Kelsen, L. A. Christensen and J. F. Dahlerup, Clinical trial: vitamin D3 treatment in Crohn’s disease - a randomized double-blind placebo-controlled study, Aliment. Pharmacol. Ther., 2010, 32, 377–383
A. Mizoguchi, Animal models of inflammatory bowel disease, Prog. Mol. Biol. Transl. Sci., 2012, 105, 263–320
M. T. Cantorna, K. McDaniel, S. Bora, J. Chen and J. James, Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease, Exp. Biol. Med., 2014, 239, 1524–1530
T. Hiratsuka, M. Inomata, S. Goto, Y. Oyama, T. Nakano, C. L. Chen, N. Shiraishi, T. Noguchi and S. Kitano, Phototherapy with artificial light suppresses dextran sulfate sodium-induced colitis in a mouse model, J. Gastroenterol. Hepatol., 2014, 29, 749–756
J. Breuer, N. Schwab, T. Schneider-Hohendorf, M. Marziniak, H. Mohan, U. Bhatia, C. C. Gross, B. E. Clausen, C. Weishaupt, T. A. Luger, S. G. Meuth, K. Loser and H. Wiendl, Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity, Ann. Neurol., 2014, 75, 739–758
D. Bruce, J. H. Ooi, S. Yu and M. T. Cantorna, Vitamin D and host resistance to infection? Putting the cart in front of the horse, Exp. Biol. Med., 2010, 235, 921–927
J. H. Ooi, J. Chen and M. T. Cantorna, Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?, Mol. Aspects Med., 2012, 33, 77–82
M. T. Cantorna, L. Snyder, Y. D. Lin and L. Yang, Vitamin D and 1,25(OH)2D regulation of T cells, Nutrients, 2015, 7, 3011–3021
T. Schwarz, Mechanisms of UV-induced immunosuppression, Keio J. Med., 2005, 54, 165–171
L. J. Saubermann, P. Beck, Y. P. De Jong, R. S. Pitman, M. S. Ryan, H. S. Kim, M. Exley, S. Snapper, S. P. Balk, S. J. Hagen, O. Kanauchi, K. Motoki, T. Sakai, C. Terhorst, Y. Koezuka, D. K. Podolsky and R. S. Blumberg, Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice, Gastroenterology, 2000, 119, 119–128
H. Cheroutre, Starting at the beginning: new perspectives on the biology of mucosal T cells, Annu. Rev. Immunol., 2004, 22, 217–246
S. Yu and M. T. Cantorna, The vitamin D receptor is required for iNKT cell development, Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 5207–5212
S. Yu, D. Bruce, M. Froicu, V. Weaver and M. T. Cantorna, Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice, Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 20834–20839
A. M. Moodycliffe, D. Nghiem, G. Clydesdale and S. E. Ullrich, Immune suppression and skin cancer development: regulation by NKT cells, Nat. Immunol., 2000, 1, 521–525
S. Gorman, J. P. McGlade, M. J. Lambert, D. H. Strickland, J. A. Thomas and P. H. Hart, UV exposure and protection against allergic airways disease, Photochem. Photobiol. Sci., 2010, 9, 571–577
K. Soontrapa, T. Honda, D. Sakata, C. Yao, T. Hirata, S. Hori, T. Matsuoka, Y. Kita, T. Shimizu, K. Kabashima and S. Narumiya, Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression, Proc. Natl. Acad. Sci. U.S.A., 2011, 108, 6668–6673
S. E. Ullrich, Photoimmune suppression and photocarcinogenesis, Front. Biosci., 2002, 7, d684–d703
A. Schwarz, F. Navid, T. Sparwasser, B. E. Clausen and T. Schwarz, 1,25-dihydroxyvitamin D exerts similar immunosuppressive effects as UVR but is dispensable for local UVR-induced immunosuppression, J. Invest. Dermatol., 2012, 132, 2762–2769
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bora, S., Cantorna, M.T. The role of UVR and vitamin D on T cells and inflammatory bowel disease. Photochem Photobiol Sci 16, 347–353 (2017). https://doi.org/10.1039/c6pp00266h
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c6pp00266h